Tokyo, Japan

Masato Nagaoka



 

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Tokyo, JP (1997 - 2011)
  • Minato-ku, JP (2014)

Company Filing History:


Years Active: 1997-2014

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Masato Nagaoka

Introduction

Masato Nagaoka is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address critical health issues. With a total of nine patents to his name, Nagaoka's work has garnered attention in the scientific community.

Latest Patents

Among his latest patents is the BCRP/ABCG2 inhibitor, which targets the breast cancer resistance protein (BCRP/ABCG2). This inhibitor features an acrylonitrile derivative or a salt thereof as its active ingredient. Another notable patent involves pharmaceutical compositions containing camptothecins. This composition includes camptothecin or its derivatives, along with various compounds such as ascorbic acid and sodium sulfite. This formulation is particularly valuable as it minimizes degradation of camptothecin during prolonged storage or exposure to light.

Career Highlights

Masato Nagaoka is associated with Kabushiki Kaisha Yakult Honsha, a company known for its commitment to health and wellness. His work at this organization has allowed him to focus on innovative solutions in the pharmaceutical sector. Nagaoka's dedication to research and development has positioned him as a key figure in his field.

Collaborations

Throughout his career, Nagaoka has collaborated with notable colleagues, including Shusuke Hashimoto and Ritsuo Aiyama. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of their collective work.

Conclusion

Masato Nagaoka's contributions to pharmaceutical innovation are noteworthy, particularly in the development of effective cancer treatments. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…